arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Trulieve Cannabis Corp.

TRLV
$8.74 ▼ -0.24 (-2.67%) at close
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
26 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
47
Health
Weak
Bearish
auto_awesome

Analytical Summary

Trulieve Cannabis Corp. faces fundamental challenges with weakness in Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.7B
Dividend Yield
Revenue Growth -3.7%
Op. Margin 12.5%
ROIC 2.4%
FCF / Share $0.29
Trailing P/E
Price / Book
FCF Yield 3.3%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

26-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$286.75M
↓ -3.7%
Net Income Profit after all expenses
$2.28M
↑ +107.9%
Operating Margin Operating profit as % of sales
12.5%
↑ +138.7% 61th
FCF / Share Free cash flow per share
$0.29
↑ +63.3%
Long-Term Debt Long-term obligations
$195.64M
↑ +43.1%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
53
Financial Health
60
Cash Quality
7

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters